BIOVECTRA Signs mRNA Tech Deal
![](https://entrevestor.com/images/uploads/_listing/BIOVECTRA_2022.jpg)
Charlottetown’s BIOVECTRA has reached a key milestone in its plans to develop one of Canada’s first mRNA vaccine manufacturing facilities, having inked a deal with pharma startup Acuitas to use the Vancouver-based company’s manufacturing technology.
Acuitas specializes in using lipid nanoparticles to deliver vaccines and other medications, with lipids being a class of organic compounds that